Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation?
Journal
Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
26
09
2021
revised:
30
10
2021
accepted:
05
11
2021
pubmed:
16
11
2021
medline:
24
11
2022
entrez:
15
11
2021
Statut:
ppublish
Résumé
The use of methamphetamines is growing worldwide with cardiovascular disease as the leading cause of mortality and morbidity. Long-term use of methamphetamines is associated with malignant hypertension, myocardial ischemia, pulmonary hypertension, and methamphetamines-associated cardiomyopathy. These effects are noted to be dose-dependent and potentially reversible with discontinuation of methamphetamines in the early stages when there is limited or no myocardial fibrosis. This review aims to (1) summarize the available data from epidemiologic studies, (2) describe pathophysiological mechanisms and clinical presentation, (3) Management of methamphetamines induced cardiomyopathy and potential complications associated with it, and (4) Strategies to reduce methamphetamines abuse and related hospitalization.
Identifiants
pubmed: 34780869
pii: S0146-2806(21)00251-6
doi: 10.1016/j.cpcardiol.2021.101042
pii:
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101042Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.